XML 35 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The changes for the three months ended March 31, 2026 in the number of Company Options outstanding related to Ordinary Shares and their related weighted average exercise prices are as follows:

 

 

Number of options

 

 

Weighted average exercise price

 

 

Weighted average remaining contractual term
(in years)

 

 

Aggregate intrinsic value
(in thousands of USD)

 

Outstanding as at December 31, 2025

 

 

20,625,368

 

 

$

13.62

 

 

 

 

 

 

 

Granted

 

 

2,274,140

 

 

$

35.07

 

 

 

 

 

 

 

Exercised

 

 

(1,971,548

)

 

$

5.60

 

 

 

 

 

 

 

Forfeited

 

 

(47,410

)

 

$

28.63

 

 

 

 

 

 

 

Outstanding as at March 31, 2026

 

 

20,880,550

 

 

$

16.68

 

 

 

7.8

 

 

 

327,595

 

Options exercisable as at March 31, 2026

 

 

10,182,441

 

 

$

12.02

 

 

 

7.1

 

 

 

203,541

 

Schedule of Weighted Average Assumptions for Stock Options Weighted average assumptions used to apply this pricing model were as follows:

 

 

 

 

Three months ended March 31,

 

 

 

 

 

2026

 

 

2025

 

Expected life (years)

 

 

 

 

6.1

 

 

 

6.1

 

Risk-free rate

 

 

 

 

3.8

%

 

 

4.4

%

Volatility

 

 

 

 

52.1

%

 

 

47.3

%

Dividend yield

 

 

 

 

0.0

%

 

 

0.0

%

Schedule of Restricted Stock Unit Activity

The changes for the three months ended March 31, 2026 in the number of RSUs outstanding are as follows:

 

 

Number of RSUs

 

 

Weighted average Fair Value Per Share

 

Outstanding as at December 31, 2025

 

 

728,283

 

 

$

25.28

 

Granted

 

 

496,390

 

 

$

35.10

 

Vested

 

 

(214,163

)

 

$

25.93

 

Forfeited/Cancelled

 

 

(2,980

)

 

$

35.45

 

Outstanding as at March 31, 2026

 

 

1,007,530

 

 

$

29.95

 

Summary of Share-Based Payment Expense

The following summarizes the share-based compensation expense recognized by type of award and line-item:

 

 

 

 

Three months ended March 31,

 

(in thousands of USD)

 

 

 

2026

 

 

2025

 

Share-based compensation expense by type of award

 

 

 

 

 

 

 

 

Share options

 

 

 

 

14,010

 

 

 

12,572

 

Restricted stock units

 

 

 

 

3,992

 

 

 

2,641

 

Total share-based compensation expense

 

 

 

 

18,002

 

 

 

15,213

 

Share-based compensation expense by line-item

 

 

 

 

 

 

 

 

Research and development expenses

 

 

 

 

6,848

 

 

 

5,223

 

Selling, general and administrative expenses

 

 

 

 

11,154

 

 

 

9,990

 

Total share-based compensation expense

 

 

 

 

18,002

 

 

 

15,213